Skip to main content
. 2020 Jan 20;33(2):145–154. doi: 10.20524/aog.2020.0448

Table 2.

Primary and secondary outcomes for patients in the Hemospray group in the included studies

graphic file with name AnnGastroenterol-33-145-g004.jpg